Stereotactic body radiotherapy with CyberKnife for cardiac malignancies

Pierluigi Bonomo, Samantha Cipressi, Isacco Desideri, Laura Masi, Raffaela Doro, Carmine Iermano, Daniela Greto, Gabriele Simontacchi, Monica Mangoni, Fabiola Paiar, Icro Meattini, Silvia Scoccianti, Gennaro Santoro, Serafina Valente, Gian Franco Gensini, Lorenzo Livi

Research output: Contribution to journalArticle

Abstract

Aims and Background: Radiobiological and technical considerations have traditionally limited the role of radiation therapy in the context of primary and secondary cardiac malignancies. Stereotactic body radiotherapy (SBRT) is a promising modality for the delivery of focused high-dose radiation with ablative potential to complex targets such as small, deep-seated, moving lesions, allowing also for re-irradiation. Methods: Between January 2013 and October 2013, 3 patients underwent SBRT for cardiac lesions: 2 patients had recurrent, previously irradiated cardiac angiosarcomas (PCA) and 1 patient had a cardiac metastasis from melanoma. They were treated with fiducial-guided robotic radiotherapy with CyberKnife. As for dose prescription, 24 Gy in 3 fractions (80% isodose) and 30 Gy in 5 fractions (80% isodose) were administered to the recurrent PCAs and cardiac metastasis, respectively. Results: At 2 months after SBRT, cardiac MRI showed a partial response in the patients treated for recurrent PCA while the cardiac metastasis remained stable. In all cases, absence of local progression was subsequently confirmed by contrast-enhanced cardiac MRI after 6 months, without any evidence of treatment-related side effects. Conclusions: Fiducial-guided SBRT proved to be feasible and effective in preventing local disease progression in selected patients with cardiac malignancies.

Original languageEnglish
Pages (from-to)294-297
Number of pages4
JournalTumori
Volume101
Issue number3
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Radiosurgery
Hemangiosarcoma
Neoplasms
Neoplasm Metastasis
Radiotherapy
Passive Cutaneous Anaphylaxis
Robotics
Prescriptions
Disease Progression
Melanoma
Radiation

Keywords

  • Cardiac angiosarcoma
  • Cardiac metastases
  • Heart
  • Stereotactic body radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Bonomo, P., Cipressi, S., Desideri, I., Masi, L., Doro, R., Iermano, C., ... Livi, L. (2015). Stereotactic body radiotherapy with CyberKnife for cardiac malignancies. Tumori, 101(3), 294-297. https://doi.org/10.5301/tj.5000280

Stereotactic body radiotherapy with CyberKnife for cardiac malignancies. / Bonomo, Pierluigi; Cipressi, Samantha; Desideri, Isacco; Masi, Laura; Doro, Raffaela; Iermano, Carmine; Greto, Daniela; Simontacchi, Gabriele; Mangoni, Monica; Paiar, Fabiola; Meattini, Icro; Scoccianti, Silvia; Santoro, Gennaro; Valente, Serafina; Gensini, Gian Franco; Livi, Lorenzo.

In: Tumori, Vol. 101, No. 3, 01.05.2015, p. 294-297.

Research output: Contribution to journalArticle

Bonomo, P, Cipressi, S, Desideri, I, Masi, L, Doro, R, Iermano, C, Greto, D, Simontacchi, G, Mangoni, M, Paiar, F, Meattini, I, Scoccianti, S, Santoro, G, Valente, S, Gensini, GF & Livi, L 2015, 'Stereotactic body radiotherapy with CyberKnife for cardiac malignancies', Tumori, vol. 101, no. 3, pp. 294-297. https://doi.org/10.5301/tj.5000280
Bonomo P, Cipressi S, Desideri I, Masi L, Doro R, Iermano C et al. Stereotactic body radiotherapy with CyberKnife for cardiac malignancies. Tumori. 2015 May 1;101(3):294-297. https://doi.org/10.5301/tj.5000280
Bonomo, Pierluigi ; Cipressi, Samantha ; Desideri, Isacco ; Masi, Laura ; Doro, Raffaela ; Iermano, Carmine ; Greto, Daniela ; Simontacchi, Gabriele ; Mangoni, Monica ; Paiar, Fabiola ; Meattini, Icro ; Scoccianti, Silvia ; Santoro, Gennaro ; Valente, Serafina ; Gensini, Gian Franco ; Livi, Lorenzo. / Stereotactic body radiotherapy with CyberKnife for cardiac malignancies. In: Tumori. 2015 ; Vol. 101, No. 3. pp. 294-297.
@article{6292192b594846fa8fbe42a50a274453,
title = "Stereotactic body radiotherapy with CyberKnife for cardiac malignancies",
abstract = "Aims and Background: Radiobiological and technical considerations have traditionally limited the role of radiation therapy in the context of primary and secondary cardiac malignancies. Stereotactic body radiotherapy (SBRT) is a promising modality for the delivery of focused high-dose radiation with ablative potential to complex targets such as small, deep-seated, moving lesions, allowing also for re-irradiation. Methods: Between January 2013 and October 2013, 3 patients underwent SBRT for cardiac lesions: 2 patients had recurrent, previously irradiated cardiac angiosarcomas (PCA) and 1 patient had a cardiac metastasis from melanoma. They were treated with fiducial-guided robotic radiotherapy with CyberKnife. As for dose prescription, 24 Gy in 3 fractions (80{\%} isodose) and 30 Gy in 5 fractions (80{\%} isodose) were administered to the recurrent PCAs and cardiac metastasis, respectively. Results: At 2 months after SBRT, cardiac MRI showed a partial response in the patients treated for recurrent PCA while the cardiac metastasis remained stable. In all cases, absence of local progression was subsequently confirmed by contrast-enhanced cardiac MRI after 6 months, without any evidence of treatment-related side effects. Conclusions: Fiducial-guided SBRT proved to be feasible and effective in preventing local disease progression in selected patients with cardiac malignancies.",
keywords = "Cardiac angiosarcoma, Cardiac metastases, Heart, Stereotactic body radiotherapy",
author = "Pierluigi Bonomo and Samantha Cipressi and Isacco Desideri and Laura Masi and Raffaela Doro and Carmine Iermano and Daniela Greto and Gabriele Simontacchi and Monica Mangoni and Fabiola Paiar and Icro Meattini and Silvia Scoccianti and Gennaro Santoro and Serafina Valente and Gensini, {Gian Franco} and Lorenzo Livi",
year = "2015",
month = "5",
day = "1",
doi = "10.5301/tj.5000280",
language = "English",
volume = "101",
pages = "294--297",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Stereotactic body radiotherapy with CyberKnife for cardiac malignancies

AU - Bonomo, Pierluigi

AU - Cipressi, Samantha

AU - Desideri, Isacco

AU - Masi, Laura

AU - Doro, Raffaela

AU - Iermano, Carmine

AU - Greto, Daniela

AU - Simontacchi, Gabriele

AU - Mangoni, Monica

AU - Paiar, Fabiola

AU - Meattini, Icro

AU - Scoccianti, Silvia

AU - Santoro, Gennaro

AU - Valente, Serafina

AU - Gensini, Gian Franco

AU - Livi, Lorenzo

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Aims and Background: Radiobiological and technical considerations have traditionally limited the role of radiation therapy in the context of primary and secondary cardiac malignancies. Stereotactic body radiotherapy (SBRT) is a promising modality for the delivery of focused high-dose radiation with ablative potential to complex targets such as small, deep-seated, moving lesions, allowing also for re-irradiation. Methods: Between January 2013 and October 2013, 3 patients underwent SBRT for cardiac lesions: 2 patients had recurrent, previously irradiated cardiac angiosarcomas (PCA) and 1 patient had a cardiac metastasis from melanoma. They were treated with fiducial-guided robotic radiotherapy with CyberKnife. As for dose prescription, 24 Gy in 3 fractions (80% isodose) and 30 Gy in 5 fractions (80% isodose) were administered to the recurrent PCAs and cardiac metastasis, respectively. Results: At 2 months after SBRT, cardiac MRI showed a partial response in the patients treated for recurrent PCA while the cardiac metastasis remained stable. In all cases, absence of local progression was subsequently confirmed by contrast-enhanced cardiac MRI after 6 months, without any evidence of treatment-related side effects. Conclusions: Fiducial-guided SBRT proved to be feasible and effective in preventing local disease progression in selected patients with cardiac malignancies.

AB - Aims and Background: Radiobiological and technical considerations have traditionally limited the role of radiation therapy in the context of primary and secondary cardiac malignancies. Stereotactic body radiotherapy (SBRT) is a promising modality for the delivery of focused high-dose radiation with ablative potential to complex targets such as small, deep-seated, moving lesions, allowing also for re-irradiation. Methods: Between January 2013 and October 2013, 3 patients underwent SBRT for cardiac lesions: 2 patients had recurrent, previously irradiated cardiac angiosarcomas (PCA) and 1 patient had a cardiac metastasis from melanoma. They were treated with fiducial-guided robotic radiotherapy with CyberKnife. As for dose prescription, 24 Gy in 3 fractions (80% isodose) and 30 Gy in 5 fractions (80% isodose) were administered to the recurrent PCAs and cardiac metastasis, respectively. Results: At 2 months after SBRT, cardiac MRI showed a partial response in the patients treated for recurrent PCA while the cardiac metastasis remained stable. In all cases, absence of local progression was subsequently confirmed by contrast-enhanced cardiac MRI after 6 months, without any evidence of treatment-related side effects. Conclusions: Fiducial-guided SBRT proved to be feasible and effective in preventing local disease progression in selected patients with cardiac malignancies.

KW - Cardiac angiosarcoma

KW - Cardiac metastases

KW - Heart

KW - Stereotactic body radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84938237589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938237589&partnerID=8YFLogxK

U2 - 10.5301/tj.5000280

DO - 10.5301/tj.5000280

M3 - Article

C2 - 25908042

AN - SCOPUS:84938237589

VL - 101

SP - 294

EP - 297

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -